PCN protects against LCA-induced liver damage by activating PXR and the downstream CYP3A11 and SULT2A1 and inhibiting the release of chemokines and cytokines by interfering with NF-κB in the liver of mice (Supplementary Figure S2). Here, NR1I2 is linked to Leber congenital amaurosis.